Dacomitinib (PF299804)

Min.Order / FOB Price:Get Latest Price

10 Gram	Negotiable

10 Gram

Negotiable

Min.Order :10 Gram
Purity: 99%
Payment Terms : L/C,T/T,,MoneyGram

Keywords

Dacomitinib (PF299804) 99%Dacomitinib (PF299804) 1110813-31-4

Quick Details

Appearance:white solid
Application:Dacomitinib (PF299804), which name is (E)-N-[4-(3-chloro-4-fluoroanilino)-7- methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide, is a potent, orally available, highly selective, irreversible small-
PackAge:As customer request
ProductionCapacity:100|Kilogram|Week
Storage:room temp
Transportation:By Sea/Air/Courier

Superiority:

Triumph Chemical Title

Triumph Company Office picture

Triumph Company advantage

Triumph Testing title picture

Triumph Testing way

Welcome to contact us

Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details:

Dacomitinib (PF299804)

CAS:	1110813-31-4
MF:	C24H25ClFN5O2
MW:	469.9390032
Appearance:	White solid
Assay:	99%
Boiling point:	665.7±55.0 °C(Predicted)
desnity:	1.344
Uses:	Dacomitinib is a selective and irreversible inhibitor of EGFR. It is a drug candidate for the treatment of non-small cell lung carcinoma. PF299804 is a potent, irreversible pan-ErbB inhibitor against ErbB1, ErbB2 and ErbB4 with IC50 of 6 nM, 45.7 nM and 73.7 nM, respectively.

View All

Visit Store

Dacomitinib (PF2998...